Scaling of Cmin [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2014-12-10 18:21 (3845 d 05:53 ago) – Posting: # 14049
Views: 15,126

Dear kumarnaidu

❝ That means we have to use the 4 way (Fully replicate) method here but with a different sequence RRTT or TTRR


No, you do not need to use a 4 period replicate design: You will have 2 periods and 2 sequences, you just need to dose until you reach steady state, take then the PK profile for the dosing interval and after an afreshed dosing for the consecutive interval.

e.g.:
1st dosing drug1
2nd dosing drug1
3rd dosing drug1
4th dosing drug1
5th dosing drug1 -> PK Profile
6th dosing drug1 -> PK Profile
1st dosing drug2
2nd dosing drug2
3rd dosing drug2
4th dosing drug2
5th dosing drug2 -> PK Profile
6th dosing drug2 -> PK Profile


Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
29 visitors (0 registered, 29 guests [including 7 identified bots]).
Forum time: 01:14 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5